Could a diabetes drug help lung patients shed pounds?
NCT ID NCT05746039
First seen Apr 25, 2026 · Last updated Apr 27, 2026 · Updated 1 time
Summary
This small study is testing whether semaglutide, a drug used for diabetes and obesity, is safe and tolerable for people with advanced lung disease. Eight participants will take the drug for 12 weeks while researchers monitor side effects, weight, and lung function. The goal is to see if this approach is feasible before larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Pennsylvania Perelman School of Medicine
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.